article thumbnail

What happened to all the antibiotics?

pharmaphorum

Moreover, more than any other medicine, antibiotics are more likely to face insufficient supply, with analysis by the US Pharmacopeia suggesting they are 42% more likely to be in shortage compared to all other drugs. Larger questions remain around the way in which to support manufacturers to invest in production capabilities for antibiotics.

article thumbnail

Why are clinical trials struggling with diversity?

pharmaphorum

Despite policies, guidelines, and regulations to promote the diversification of clinical trial groups by the European Medicines Agency (EMA) and FDA, the inclusion of key demographic populations within clinical research continues to be less than proportionate to their representation in society. About the authors.

Packaging 128